Search

目的研究术中使用改良腋位透视的方法判断肩锁关节脱位患者的锁骨远端水平方向的向后移是否得到了纠正。方法2019年2月-2021年4月，将符合纳入标准的肩锁关节脱位（分型为RockwoodⅢ型）患者共50例，分常规组和改良腋位透视组，常规组32例，改良腋位透视组18例。常规组术中采用常规正位片透视检测复位效果，改良腋位透视组在术中透视改良腋位片的基础上，引入极坐标概念指导纠正水平方向的后移位，并比较两组患者的平均手术时间、术中出血量等围手术期参数的差异，术后随访使用Constant评分评估两组患者肩关节功能恢复情况。结果入选的两组患者在性别、年龄、受伤时间、合并基础疾病等因素的均衡性方面差异无统计学意义，两组患者在术中出血量、手术时间方面差异均无统计学意义。改良腋位透视组肩关节术后功能评分高于常规组。结论术中透视改良腋位有助于准确的复位锁骨远端水平方向的后移位，对锁骨钩的准确置入也有参考意义。

Copyright of Control Theory & Applications / Kongzhi Lilun Yu Yinyong is the property of Editorial Department of Control Theory & Applications and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Shandong Medical Journal is the property of Shandong Medical Health Newspapers and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Cotton Textile Technology is the property of Cotton Textile Technology Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Laboratory Medicine is the property of Journal of Modern Laboratory Medicine Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Modern Medicine & Health is the property of Journal of Modern Medicine & Health and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

With the improvement of diagnosis and treatment, tumor has become a chronic disease, and an increasing number of older patients will live with tumors. This change has led to an increase in demand for intensive care unit (ICU) and a challenge to the traditional ICU treatment concept. The option of ICU consists of two parts. The first is the option for admission. Since classic predictors of mortality are no longer relevant, we suggest broadening the criteria for ICU admission. Patients during the first course of cancer therapies should be treated with a full-code status similar to that of other patients without malignancy. Patients whose clinical response to therapy was not available or undetermined should be allowed an ICU trial that consists of unlimited invasive support, including anti-cancer therapies such as ambulatory chemotherapy. Do everything that can be done to save the patients who might benefit from ICU treatment. The second is the option of therapeutic end point. An interdisciplinary meeting, including an ethics consultation, should be held after 3-6 days′ICU trial to make end-of-life decisions with relatives of patients if the SOFA score shows clinical deterioration with no available therapeutic options. The treatment goals should shift from curative or supportive therapies to end-of-life care. we could integrate hospice and palliative care with intensive care more effectively and efficiently. That would be the future of oncological ICUs. [ABSTRACT FROM AUTHOR]

Copyright of Computer Measurement & Control is the property of Magazine Agency of Computer Measurement & Control and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

夏睿明1924年生，早年拜师于名老中医杨植樨、 唐阳春门下学习岐黄之术，系重庆医科大学附属第一医院中医科创始 人，1958年开始担任中医科主任兼中医教研室主任，重庆医科大学教 授，从教30余载，行医七十春秋。历任农工民主党重庆市委委员、重 庆市中医药学会常务理事、四川省中医学会理事暨内科专业委员会 副主任委员、四川省中医高级职称评委，重庆市首批名老中医，“两会 一党”中央中药咨询服务理事会委员，在参加中国农工民主党第九次 全国代表大会受到党和国家领导人的接见。退休后任重庆市中医药 学会顾问委员会副主任委员、《实用中医药杂志》顾问等职。先后发表 学术论文30余篇，《柴胡加龙骨牡蛎汤临床应用》及《经方运用举隅》 等多次获得四川省、重庆市中医学会奖。 [ABSTRACT FROM AUTHOR]

该案患儿因外感服用了西药处方感冒药后出现听力下降，先后到重庆医科大学附属第二医院、重庆医科大学附属儿童医院就诊，确诊为突发性耳聋、急性播散性脑脊髓炎，表现为面瘫、听力减退、四肢无力、眼睛聚焦困难、身体平衡能力变差。住院期间使用丙种球蛋白、泼尼松对症治疗，出院后继续口服泼尼松龙片、钙片，辅以高压氧和脑循环治疗，仍未痊愈。2015年2月1日来诊，内服中药汤剂3个月后，上述症状已全部消失，核磁共振复查显示病灶完全被吸收。 [ABSTRACT FROM AUTHOR]

该案患儿病情缠绵冗长，首诊血虚症状尤甚，且在此之前已寻遍川渝名医，收效甚微，极易反复。夏老结合辨证、辨病定为血虚寒凝、经脉失养所致。与严用和的“充任极虚，血海极寒”和清代萧慎斋之“崩中日久，则热变为寒。亦有服寒冷过剩者，中寒内生者。”不谋而合。宜温经散寒，固经养血，温经汤遣之。守方两月余，随诊半年崩漏未复发，余证皆消，体态充盈。 [ABSTRACT FROM AUTHOR]

逍遥散素有女性圣药之称，是宋代《太平惠民和剂局方》记载的名方，曾被誉为“肝病第一良方”和产后虚热的专方。其功效重在疏肝解郁、养血健脾，主治肝郁血虚脾弱证。明代以后，逍遥散的应用不断扩展， 广泛应用于内、外、妇、儿、五官科各疑难病的治疗。然而，夏老深悟中医学的“异病同治”精髓，独辟蹊径，将其成功用于治疗小儿多动症，效果明显，且治愈率为100%，实属少见。 [ABSTRACT FROM AUTHOR]